nodes	percent_of_prediction	percent_of_DWPC	metapath
Ganciclovir—SLC22A1—Cytarabine—lymphatic system cancer	0.33	0.514	CbGbCtD
Ganciclovir—SLC22A7—Methotrexate—lymphatic system cancer	0.153	0.239	CbGbCtD
Ganciclovir—SLC22A8—Methotrexate—lymphatic system cancer	0.0936	0.146	CbGbCtD
Ganciclovir—SLC22A6—Methotrexate—lymphatic system cancer	0.0652	0.101	CbGbCtD
Ganciclovir—Confusional state—Bleomycin—lymphatic system cancer	0.000398	0.00111	CcSEcCtD
Ganciclovir—Vision blurred—Carmustine—lymphatic system cancer	0.000398	0.00111	CcSEcCtD
Ganciclovir—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000396	0.00111	CcSEcCtD
Ganciclovir—Tremor—Carmustine—lymphatic system cancer	0.000395	0.00111	CcSEcCtD
Ganciclovir—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000395	0.0011	CcSEcCtD
Ganciclovir—Oedema—Bleomycin—lymphatic system cancer	0.000395	0.0011	CcSEcCtD
Ganciclovir—Infection—Bleomycin—lymphatic system cancer	0.000392	0.0011	CcSEcCtD
Ganciclovir—Anaemia—Carmustine—lymphatic system cancer	0.00039	0.00109	CcSEcCtD
Ganciclovir—Back pain—Vincristine—lymphatic system cancer	0.00039	0.00109	CcSEcCtD
Ganciclovir—Vomiting—Teniposide—lymphatic system cancer	0.000389	0.00109	CcSEcCtD
Ganciclovir—Sepsis—Methotrexate—lymphatic system cancer	0.000388	0.00108	CcSEcCtD
Ganciclovir—Agitation—Carmustine—lymphatic system cancer	0.000388	0.00108	CcSEcCtD
Ganciclovir—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000386	0.00108	CcSEcCtD
Ganciclovir—Asthenia—Fludarabine—lymphatic system cancer	0.000386	0.00108	CcSEcCtD
Ganciclovir—Rash—Teniposide—lymphatic system cancer	0.000386	0.00108	CcSEcCtD
Ganciclovir—Dermatitis—Teniposide—lymphatic system cancer	0.000386	0.00108	CcSEcCtD
Ganciclovir—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000384	0.00107	CcSEcCtD
Ganciclovir—Headache—Teniposide—lymphatic system cancer	0.000384	0.00107	CcSEcCtD
Ganciclovir—Pruritus—Fludarabine—lymphatic system cancer	0.000381	0.00106	CcSEcCtD
Ganciclovir—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.00038	0.00106	CcSEcCtD
Ganciclovir—Back pain—Mitoxantrone—lymphatic system cancer	0.000379	0.00106	CcSEcCtD
Ganciclovir—Leukopenia—Carmustine—lymphatic system cancer	0.000378	0.00106	CcSEcCtD
Ganciclovir—Anorexia—Bleomycin—lymphatic system cancer	0.000376	0.00105	CcSEcCtD
Ganciclovir—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.000375	0.00105	CcSEcCtD
Ganciclovir—Anaemia—Vincristine—lymphatic system cancer	0.000372	0.00104	CcSEcCtD
Ganciclovir—Agitation—Vincristine—lymphatic system cancer	0.00037	0.00103	CcSEcCtD
Ganciclovir—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00037	0.00103	CcSEcCtD
Ganciclovir—Hypotension—Bleomycin—lymphatic system cancer	0.000369	0.00103	CcSEcCtD
Ganciclovir—Diarrhoea—Fludarabine—lymphatic system cancer	0.000368	0.00103	CcSEcCtD
Ganciclovir—Convulsion—Carmustine—lymphatic system cancer	0.000366	0.00102	CcSEcCtD
Ganciclovir—Hypertension—Carmustine—lymphatic system cancer	0.000364	0.00102	CcSEcCtD
Ganciclovir—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000364	0.00102	CcSEcCtD
Ganciclovir—Nausea—Teniposide—lymphatic system cancer	0.000364	0.00102	CcSEcCtD
Ganciclovir—Anaemia—Mitoxantrone—lymphatic system cancer	0.000363	0.00101	CcSEcCtD
Ganciclovir—Vertigo—Vincristine—lymphatic system cancer	0.000362	0.00101	CcSEcCtD
Ganciclovir—Hepatic failure—Methotrexate—lymphatic system cancer	0.000361	0.00101	CcSEcCtD
Ganciclovir—Leukopenia—Vincristine—lymphatic system cancer	0.000361	0.00101	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000359	0.001	CcSEcCtD
Ganciclovir—Chest pain—Carmustine—lymphatic system cancer	0.000359	0.001	CcSEcCtD
Ganciclovir—Myalgia—Carmustine—lymphatic system cancer	0.000359	0.001	CcSEcCtD
Ganciclovir—Anxiety—Carmustine—lymphatic system cancer	0.000358	0.001	CcSEcCtD
Ganciclovir—Paraesthesia—Bleomycin—lymphatic system cancer	0.000354	0.00099	CcSEcCtD
Ganciclovir—Malaise—Mitoxantrone—lymphatic system cancer	0.000354	0.000989	CcSEcCtD
Ganciclovir—Dyspnoea—Bleomycin—lymphatic system cancer	0.000352	0.000983	CcSEcCtD
Ganciclovir—Renal failure acute—Methotrexate—lymphatic system cancer	0.000352	0.000983	CcSEcCtD
Ganciclovir—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000351	0.000982	CcSEcCtD
Ganciclovir—Convulsion—Vincristine—lymphatic system cancer	0.000349	0.000976	CcSEcCtD
Ganciclovir—Hypertension—Vincristine—lymphatic system cancer	0.000348	0.000972	CcSEcCtD
Ganciclovir—Confusional state—Carmustine—lymphatic system cancer	0.000347	0.000971	CcSEcCtD
Ganciclovir—Oedema—Carmustine—lymphatic system cancer	0.000344	0.000963	CcSEcCtD
Ganciclovir—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.000344	0.000962	CcSEcCtD
Ganciclovir—Decreased appetite—Bleomycin—lymphatic system cancer	0.000343	0.000959	CcSEcCtD
Ganciclovir—Myalgia—Vincristine—lymphatic system cancer	0.000343	0.000959	CcSEcCtD
Ganciclovir—Cough—Mitoxantrone—lymphatic system cancer	0.000342	0.000957	CcSEcCtD
Ganciclovir—Infection—Carmustine—lymphatic system cancer	0.000342	0.000957	CcSEcCtD
Ganciclovir—Vomiting—Fludarabine—lymphatic system cancer	0.000342	0.000957	CcSEcCtD
Ganciclovir—Convulsion—Mitoxantrone—lymphatic system cancer	0.00034	0.00095	CcSEcCtD
Ganciclovir—Rash—Fludarabine—lymphatic system cancer	0.000339	0.000949	CcSEcCtD
Ganciclovir—Dermatitis—Fludarabine—lymphatic system cancer	0.000339	0.000948	CcSEcCtD
Ganciclovir—Hypertension—Mitoxantrone—lymphatic system cancer	0.000339	0.000947	CcSEcCtD
Ganciclovir—Pain—Bleomycin—lymphatic system cancer	0.000337	0.000943	CcSEcCtD
Ganciclovir—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000337	0.000943	CcSEcCtD
Ganciclovir—Headache—Fludarabine—lymphatic system cancer	0.000337	0.000942	CcSEcCtD
Ganciclovir—Tachycardia—Carmustine—lymphatic system cancer	0.000336	0.00094	CcSEcCtD
Ganciclovir—Myalgia—Mitoxantrone—lymphatic system cancer	0.000334	0.000934	CcSEcCtD
Ganciclovir—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000334	0.000934	CcSEcCtD
Ganciclovir—Chest pain—Mitoxantrone—lymphatic system cancer	0.000334	0.000934	CcSEcCtD
Ganciclovir—Anxiety—Mitoxantrone—lymphatic system cancer	0.000333	0.000931	CcSEcCtD
Ganciclovir—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.000331	0.000926	CcSEcCtD
Ganciclovir—Discomfort—Mitoxantrone—lymphatic system cancer	0.00033	0.000923	CcSEcCtD
Ganciclovir—Oedema—Vincristine—lymphatic system cancer	0.000329	0.000919	CcSEcCtD
Ganciclovir—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000329	0.000919	CcSEcCtD
Ganciclovir—Anorexia—Carmustine—lymphatic system cancer	0.000328	0.000918	CcSEcCtD
Ganciclovir—Infection—Vincristine—lymphatic system cancer	0.000327	0.000913	CcSEcCtD
Ganciclovir—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000325	0.000909	CcSEcCtD
Ganciclovir—Confusional state—Mitoxantrone—lymphatic system cancer	0.000323	0.000903	CcSEcCtD
Ganciclovir—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000322	0.0009	CcSEcCtD
Ganciclovir—Hypotension—Carmustine—lymphatic system cancer	0.000322	0.0009	CcSEcCtD
Ganciclovir—Oedema—Mitoxantrone—lymphatic system cancer	0.00032	0.000895	CcSEcCtD
Ganciclovir—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00032	0.000895	CcSEcCtD
Ganciclovir—Nausea—Fludarabine—lymphatic system cancer	0.00032	0.000894	CcSEcCtD
Ganciclovir—Infection—Mitoxantrone—lymphatic system cancer	0.000318	0.000889	CcSEcCtD
Ganciclovir—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000318	0.000889	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000314	0.000877	CcSEcCtD
Ganciclovir—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000313	0.000876	CcSEcCtD
Ganciclovir—Urticaria—Bleomycin—lymphatic system cancer	0.000313	0.000876	CcSEcCtD
Ganciclovir—Anorexia—Vincristine—lymphatic system cancer	0.000313	0.000876	CcSEcCtD
Ganciclovir—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000312	0.000874	CcSEcCtD
Ganciclovir—Body temperature increased—Bleomycin—lymphatic system cancer	0.000312	0.000872	CcSEcCtD
Ganciclovir—Insomnia—Carmustine—lymphatic system cancer	0.000311	0.000871	CcSEcCtD
Ganciclovir—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000311	0.000869	CcSEcCtD
Ganciclovir—Irritability—Methotrexate—lymphatic system cancer	0.00031	0.000866	CcSEcCtD
Ganciclovir—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00031	0.000865	CcSEcCtD
Ganciclovir—Paraesthesia—Carmustine—lymphatic system cancer	0.000309	0.000865	CcSEcCtD
Ganciclovir—Mood swings—Methotrexate—lymphatic system cancer	0.000307	0.00086	CcSEcCtD
Ganciclovir—Hypotension—Vincristine—lymphatic system cancer	0.000307	0.000859	CcSEcCtD
Ganciclovir—Dyspnoea—Carmustine—lymphatic system cancer	0.000307	0.000858	CcSEcCtD
Ganciclovir—Somnolence—Carmustine—lymphatic system cancer	0.000306	0.000856	CcSEcCtD
Ganciclovir—Anorexia—Mitoxantrone—lymphatic system cancer	0.000305	0.000853	CcSEcCtD
Ganciclovir—Ataxia—Methotrexate—lymphatic system cancer	0.000305	0.000853	CcSEcCtD
Ganciclovir—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.0003	0.000838	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.0003	0.000837	CcSEcCtD
Ganciclovir—Decreased appetite—Carmustine—lymphatic system cancer	0.000299	0.000837	CcSEcCtD
Ganciclovir—Hypotension—Mitoxantrone—lymphatic system cancer	0.000299	0.000836	CcSEcCtD
Ganciclovir—Insomnia—Vincristine—lymphatic system cancer	0.000297	0.000831	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000297	0.000831	CcSEcCtD
Ganciclovir—Paraesthesia—Vincristine—lymphatic system cancer	0.000295	0.000825	CcSEcCtD
Ganciclovir—Pain—Carmustine—lymphatic system cancer	0.000295	0.000823	CcSEcCtD
Ganciclovir—Constipation—Carmustine—lymphatic system cancer	0.000295	0.000823	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000292	0.000816	CcSEcCtD
Ganciclovir—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000291	0.000813	CcSEcCtD
Ganciclovir—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000287	0.000804	CcSEcCtD
Ganciclovir—Decreased appetite—Vincristine—lymphatic system cancer	0.000286	0.000799	CcSEcCtD
Ganciclovir—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000285	0.000798	CcSEcCtD
Ganciclovir—Somnolence—Mitoxantrone—lymphatic system cancer	0.000285	0.000796	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000284	0.000794	CcSEcCtD
Ganciclovir—Feeling abnormal—Carmustine—lymphatic system cancer	0.000284	0.000793	CcSEcCtD
Ganciclovir—Fatigue—Vincristine—lymphatic system cancer	0.000283	0.000792	CcSEcCtD
Ganciclovir—Asthenia—Bleomycin—lymphatic system cancer	0.000283	0.000791	CcSEcCtD
Ganciclovir—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000282	0.000788	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000282	0.000787	CcSEcCtD
Ganciclovir—Constipation—Vincristine—lymphatic system cancer	0.000281	0.000786	CcSEcCtD
Ganciclovir—Pain—Vincristine—lymphatic system cancer	0.000281	0.000786	CcSEcCtD
Ganciclovir—Pruritus—Bleomycin—lymphatic system cancer	0.000279	0.00078	CcSEcCtD
Ganciclovir—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000278	0.000778	CcSEcCtD
Ganciclovir—Eosinophilia—Methotrexate—lymphatic system cancer	0.000278	0.000777	CcSEcCtD
Ganciclovir—Fatigue—Mitoxantrone—lymphatic system cancer	0.000276	0.000772	CcSEcCtD
Ganciclovir—Pancreatitis—Methotrexate—lymphatic system cancer	0.000275	0.000769	CcSEcCtD
Ganciclovir—Constipation—Mitoxantrone—lymphatic system cancer	0.000274	0.000765	CcSEcCtD
Ganciclovir—Pain—Mitoxantrone—lymphatic system cancer	0.000274	0.000765	CcSEcCtD
Ganciclovir—Abdominal pain—Carmustine—lymphatic system cancer	0.000272	0.000761	CcSEcCtD
Ganciclovir—Body temperature increased—Carmustine—lymphatic system cancer	0.000272	0.000761	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000269	0.000752	CcSEcCtD
Ganciclovir—Pancytopenia—Methotrexate—lymphatic system cancer	0.000266	0.000745	CcSEcCtD
Ganciclovir—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000264	0.000738	CcSEcCtD
Ganciclovir—Neutropenia—Methotrexate—lymphatic system cancer	0.000262	0.000733	CcSEcCtD
Ganciclovir—Dysuria—Methotrexate—lymphatic system cancer	0.000262	0.000733	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000262	0.000732	CcSEcCtD
Ganciclovir—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000261	0.000729	CcSEcCtD
Ganciclovir—Abdominal pain—Vincristine—lymphatic system cancer	0.00026	0.000727	CcSEcCtD
Ganciclovir—Body temperature increased—Vincristine—lymphatic system cancer	0.00026	0.000727	CcSEcCtD
Ganciclovir—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000258	0.000722	CcSEcCtD
Ganciclovir—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000256	0.000716	CcSEcCtD
Ganciclovir—Urticaria—Mitoxantrone—lymphatic system cancer	0.000254	0.000711	CcSEcCtD
Ganciclovir—Hypersensitivity—Carmustine—lymphatic system cancer	0.000254	0.000709	CcSEcCtD
Ganciclovir—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000253	0.000708	CcSEcCtD
Ganciclovir—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000253	0.000708	CcSEcCtD
Ganciclovir—Pneumonia—Methotrexate—lymphatic system cancer	0.000252	0.000703	CcSEcCtD
Ganciclovir—Vomiting—Bleomycin—lymphatic system cancer	0.000251	0.000701	CcSEcCtD
Ganciclovir—Infestation—Methotrexate—lymphatic system cancer	0.00025	0.000699	CcSEcCtD
Ganciclovir—Infestation NOS—Methotrexate—lymphatic system cancer	0.00025	0.000699	CcSEcCtD
Ganciclovir—Rash—Bleomycin—lymphatic system cancer	0.000249	0.000695	CcSEcCtD
Ganciclovir—Dermatitis—Bleomycin—lymphatic system cancer	0.000249	0.000695	CcSEcCtD
Ganciclovir—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000248	0.000693	CcSEcCtD
Ganciclovir—Asthenia—Carmustine—lymphatic system cancer	0.000247	0.000691	CcSEcCtD
Ganciclovir—Renal failure—Methotrexate—lymphatic system cancer	0.000246	0.000687	CcSEcCtD
Ganciclovir—Stomatitis—Methotrexate—lymphatic system cancer	0.000244	0.000682	CcSEcCtD
Ganciclovir—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000243	0.00068	CcSEcCtD
Ganciclovir—Hypersensitivity—Vincristine—lymphatic system cancer	0.000242	0.000677	CcSEcCtD
Ganciclovir—Sweating—Methotrexate—lymphatic system cancer	0.00024	0.00067	CcSEcCtD
Ganciclovir—Haematuria—Methotrexate—lymphatic system cancer	0.000238	0.000667	CcSEcCtD
Ganciclovir—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000237	0.000661	CcSEcCtD
Ganciclovir—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000236	0.000659	CcSEcCtD
Ganciclovir—Asthenia—Vincristine—lymphatic system cancer	0.000236	0.000659	CcSEcCtD
Ganciclovir—Diarrhoea—Carmustine—lymphatic system cancer	0.000236	0.000659	CcSEcCtD
Ganciclovir—Nausea—Bleomycin—lymphatic system cancer	0.000234	0.000655	CcSEcCtD
Ganciclovir—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000233	0.000653	CcSEcCtD
Ganciclovir—Asthenia—Mitoxantrone—lymphatic system cancer	0.00023	0.000642	CcSEcCtD
Ganciclovir—Dizziness—Carmustine—lymphatic system cancer	0.000228	0.000637	CcSEcCtD
Ganciclovir—Haemoglobin—Methotrexate—lymphatic system cancer	0.000226	0.000631	CcSEcCtD
Ganciclovir—Diarrhoea—Vincristine—lymphatic system cancer	0.000225	0.000629	CcSEcCtD
Ganciclovir—Haemorrhage—Methotrexate—lymphatic system cancer	0.000225	0.000628	CcSEcCtD
Ganciclovir—Hepatitis—Methotrexate—lymphatic system cancer	0.000225	0.000628	CcSEcCtD
Ganciclovir—Pharyngitis—Methotrexate—lymphatic system cancer	0.000223	0.000623	CcSEcCtD
Ganciclovir—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000222	0.00062	CcSEcCtD
Ganciclovir—Urethral disorder—Methotrexate—lymphatic system cancer	0.00022	0.000615	CcSEcCtD
Ganciclovir—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000219	0.000612	CcSEcCtD
Ganciclovir—Vomiting—Carmustine—lymphatic system cancer	0.000219	0.000612	CcSEcCtD
Ganciclovir—Dizziness—Vincristine—lymphatic system cancer	0.000217	0.000608	CcSEcCtD
Ganciclovir—Rash—Carmustine—lymphatic system cancer	0.000217	0.000607	CcSEcCtD
Ganciclovir—Dermatitis—Carmustine—lymphatic system cancer	0.000217	0.000607	CcSEcCtD
Ganciclovir—Visual impairment—Methotrexate—lymphatic system cancer	0.000216	0.000605	CcSEcCtD
Ganciclovir—Headache—Carmustine—lymphatic system cancer	0.000216	0.000603	CcSEcCtD
Ganciclovir—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000212	0.000594	CcSEcCtD
Ganciclovir—Tinnitus—Methotrexate—lymphatic system cancer	0.000209	0.000585	CcSEcCtD
Ganciclovir—Vomiting—Vincristine—lymphatic system cancer	0.000209	0.000584	CcSEcCtD
Ganciclovir—Rash—Vincristine—lymphatic system cancer	0.000207	0.00058	CcSEcCtD
Ganciclovir—Dermatitis—Vincristine—lymphatic system cancer	0.000207	0.000579	CcSEcCtD
Ganciclovir—Headache—Vincristine—lymphatic system cancer	0.000206	0.000576	CcSEcCtD
Ganciclovir—Nausea—Carmustine—lymphatic system cancer	0.000205	0.000572	CcSEcCtD
Ganciclovir—Angiopathy—Methotrexate—lymphatic system cancer	0.000204	0.00057	CcSEcCtD
Ganciclovir—Vomiting—Mitoxantrone—lymphatic system cancer	0.000204	0.000569	CcSEcCtD
Ganciclovir—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000202	0.000566	CcSEcCtD
Ganciclovir—Rash—Mitoxantrone—lymphatic system cancer	0.000202	0.000564	CcSEcCtD
Ganciclovir—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000202	0.000564	CcSEcCtD
Ganciclovir—Chills—Methotrexate—lymphatic system cancer	0.000201	0.000563	CcSEcCtD
Ganciclovir—Headache—Mitoxantrone—lymphatic system cancer	0.000201	0.000561	CcSEcCtD
Ganciclovir—Alopecia—Methotrexate—lymphatic system cancer	0.000198	0.000555	CcSEcCtD
Ganciclovir—Mental disorder—Methotrexate—lymphatic system cancer	0.000197	0.00055	CcSEcCtD
Ganciclovir—Malnutrition—Methotrexate—lymphatic system cancer	0.000195	0.000546	CcSEcCtD
Ganciclovir—Nausea—Vincristine—lymphatic system cancer	0.000195	0.000546	CcSEcCtD
Ganciclovir—Dysgeusia—Methotrexate—lymphatic system cancer	0.000191	0.000535	CcSEcCtD
Ganciclovir—Nausea—Mitoxantrone—lymphatic system cancer	0.00019	0.000532	CcSEcCtD
Ganciclovir—Back pain—Methotrexate—lymphatic system cancer	0.000189	0.000529	CcSEcCtD
Ganciclovir—Vision blurred—Methotrexate—lymphatic system cancer	0.000184	0.000515	CcSEcCtD
Ganciclovir—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000181	0.000507	CcSEcCtD
Ganciclovir—Anaemia—Methotrexate—lymphatic system cancer	0.000181	0.000505	CcSEcCtD
Ganciclovir—Malaise—Methotrexate—lymphatic system cancer	0.000176	0.000493	CcSEcCtD
Ganciclovir—Vertigo—Methotrexate—lymphatic system cancer	0.000176	0.000491	CcSEcCtD
Ganciclovir—Leukopenia—Methotrexate—lymphatic system cancer	0.000175	0.000489	CcSEcCtD
Ganciclovir—Cough—Methotrexate—lymphatic system cancer	0.000171	0.000477	CcSEcCtD
Ganciclovir—Convulsion—Methotrexate—lymphatic system cancer	0.000169	0.000473	CcSEcCtD
Ganciclovir—Chest pain—Methotrexate—lymphatic system cancer	0.000166	0.000465	CcSEcCtD
Ganciclovir—Arthralgia—Methotrexate—lymphatic system cancer	0.000166	0.000465	CcSEcCtD
Ganciclovir—Myalgia—Methotrexate—lymphatic system cancer	0.000166	0.000465	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000165	0.000462	CcSEcCtD
Ganciclovir—Discomfort—Methotrexate—lymphatic system cancer	0.000164	0.00046	CcSEcCtD
Ganciclovir—Confusional state—Methotrexate—lymphatic system cancer	0.000161	0.00045	CcSEcCtD
Ganciclovir—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.00016	0.000446	CcSEcCtD
Ganciclovir—Infection—Methotrexate—lymphatic system cancer	0.000158	0.000443	CcSEcCtD
Ganciclovir—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000156	0.000437	CcSEcCtD
Ganciclovir—Skin disorder—Methotrexate—lymphatic system cancer	0.000155	0.000433	CcSEcCtD
Ganciclovir—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000154	0.000431	CcSEcCtD
Ganciclovir—Anorexia—Methotrexate—lymphatic system cancer	0.000152	0.000425	CcSEcCtD
Ganciclovir—Hypotension—Methotrexate—lymphatic system cancer	0.000149	0.000417	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000145	0.000406	CcSEcCtD
Ganciclovir—Insomnia—Methotrexate—lymphatic system cancer	0.000144	0.000403	CcSEcCtD
Ganciclovir—Paraesthesia—Methotrexate—lymphatic system cancer	0.000143	0.0004	CcSEcCtD
Ganciclovir—Dyspnoea—Methotrexate—lymphatic system cancer	0.000142	0.000398	CcSEcCtD
Ganciclovir—Somnolence—Methotrexate—lymphatic system cancer	0.000142	0.000396	CcSEcCtD
Ganciclovir—Dyspepsia—Methotrexate—lymphatic system cancer	0.00014	0.000393	CcSEcCtD
Ganciclovir—Decreased appetite—Methotrexate—lymphatic system cancer	0.000139	0.000388	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000138	0.000385	CcSEcCtD
Ganciclovir—Fatigue—Methotrexate—lymphatic system cancer	0.000138	0.000385	CcSEcCtD
Ganciclovir—Pain—Methotrexate—lymphatic system cancer	0.000136	0.000381	CcSEcCtD
Ganciclovir—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000131	0.000368	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00013	0.000365	CcSEcCtD
Ganciclovir—Urticaria—Methotrexate—lymphatic system cancer	0.000127	0.000354	CcSEcCtD
Ganciclovir—Abdominal pain—Methotrexate—lymphatic system cancer	0.000126	0.000353	CcSEcCtD
Ganciclovir—Body temperature increased—Methotrexate—lymphatic system cancer	0.000126	0.000353	CcSEcCtD
Ganciclovir—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000118	0.000329	CcSEcCtD
Ganciclovir—Asthenia—Methotrexate—lymphatic system cancer	0.000114	0.00032	CcSEcCtD
Ganciclovir—Pruritus—Methotrexate—lymphatic system cancer	0.000113	0.000316	CcSEcCtD
Ganciclovir—Diarrhoea—Methotrexate—lymphatic system cancer	0.000109	0.000305	CcSEcCtD
Ganciclovir—Dizziness—Methotrexate—lymphatic system cancer	0.000105	0.000295	CcSEcCtD
Ganciclovir—Vomiting—Methotrexate—lymphatic system cancer	0.000101	0.000284	CcSEcCtD
Ganciclovir—Rash—Methotrexate—lymphatic system cancer	0.000101	0.000281	CcSEcCtD
Ganciclovir—Dermatitis—Methotrexate—lymphatic system cancer	0.0001	0.000281	CcSEcCtD
Ganciclovir—Headache—Methotrexate—lymphatic system cancer	9.99e-05	0.000279	CcSEcCtD
Ganciclovir—Nausea—Methotrexate—lymphatic system cancer	9.48e-05	0.000265	CcSEcCtD
